Share

    


Home / Search Results

Search Results

You searched for:

In addition to the global pandemic, ongoing lawsuits from referenced biologics' manufacturers suing biosimilar manufacturers are having a negative impact on the development and approval of new biosimilars.
Because of the COVID-19 pandemic, Wilmot Cancer Institute's integrative oncology team shares how integrative oncology-based services can be delivered via telehealth.
Before the COVID-19 pandemic, patients with cancer received care in three settings: hospital inpatient, hospital emergency room, and the outpatient clinic. But just as the pandemic overturned deep-rooted barriers to telehealth uptake, it also brought renewed attention to the hospital-at-home model.
To meet patients’ needs during the height of the pandemic, this cancer program created a collaborative and more efficient hybrid-style Integrative Therapy Program for all of its oncology sites.
Lessons from the COVID-19 pandemic and from healthcare organizations actively engaged in assessing care delivery through the lens of health equity can serve as guideposts for the oncology community on the path to making cancer care more equitable.
As we turn the corner toward 2022, for oncology to drive equity forward: We need every member and every discipline, patient, leader, payer, industry partner, and innovator working together to provide the most equitable care possible in a sustainable way.
Presbyterian Healthcare Services developed a unique service, offering patients with cancer certain clinical interventions and wellness checks in the comfort of their home that is provided by the Albuquerque Ambulance Service Mobile Integrated Health team.